Literature DB >> 8627101

Immunocytologic detection of isolated tumor cells in bone marrow of patients with squamous cell carcinomas of the head and neck region.

H J Gath1, E Heissler, B Hell, J Bier, G Riethmüller, K Pantel.   

Abstract

The well-documented specificity of anticytokeratin monoclonal antibodies for detection of epithelial micrometastatic cancer cells in bone marrow as a prognostic indicator inspired us to apply this approach to patients with squamous cell carcinomas (SSC) of the head and neck region. The sensitivity of the broad-spectrum anticytokeratin monoclonal antibody (mAb) A45-B/B3 used for tumor cell detection was demonstrated by immunostaining of cryostat sections from the respective primary tumors. Analysis of 31 patients with SSC revealed A45-B/B3-positive cells in 10 cases (32.3%) at frequencies of 1-207 per 1 x 10(6) mononuclear cells. Most specimens displayed isolated tumor cells, while cell clusters were found in only two cases (6.5%). The present data suggest that hematogenous dissemination of cancer cells is more frequent than expected from clinicopathologic staging of patients with SSC of the head and neck region.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8627101     DOI: 10.1016/s0901-5027(05)80490-4

Source DB:  PubMed          Journal:  Int J Oral Maxillofac Surg        ISSN: 0901-5027            Impact factor:   2.789


  5 in total

1.  Head and neck cancer and precancer: can we use molecular genetics to make better predictions?

Authors:  M Partridge
Journal:  Ann R Coll Surg Engl       Date:  1999-01       Impact factor: 1.891

2.  Detection of bone marrow micrometastases in the rib marrow of head and neck cancer patients: a prospective pilot study.

Authors:  Liam J Skinner; Brendan J Conlon; John D Russell; Gerald C O'sullivan; Tadhg P O'dwyer
Journal:  Eur Arch Otorhinolaryngol       Date:  2004-06-09       Impact factor: 2.503

3.  VEGFR-1 expression levels predict occurrence of disseminated tumor cells in the bone marrow of patients with esophageal carcinoma.

Authors:  Alexander Schultze; Isabel Ben Batalla; Sabine Riethdorf; Michael Bubenheim; Emre Yekebas; Andreas Erbersdobler; Uta Reichelt; Katharina E Effenberger; Thomas Schmidt; Jakob R Izbicki; Carsten Bokemeyer; Klaus Pantel; Walter Fiedler; Sonja Loges
Journal:  Clin Exp Metastasis       Date:  2012-04-08       Impact factor: 5.150

4.  Cytokeratin 17 mRNA as a prognostic marker of oral squamous cell carcinoma.

Authors:  Ryoji Kitamura; Takeshi Toyoshima; Hideaki Tanaka; Shintaro Kawano; Ryota Matsubara; Yuichi Goto; Teppei Jinno; Yasuyuki Maruse; Kazunari Oobu; Seiji Nakamura
Journal:  Oncol Lett       Date:  2017-09-26       Impact factor: 2.967

Review 5.  Clinical applications of liquid biopsy in HPV-negative and HPV-positive head and neck squamous cell carcinoma: advances and challenges.

Authors:  Mariana Chantre-Justino; Gilda Alves; Lucas Delmonico
Journal:  Explor Target Antitumor Ther       Date:  2022-08-31
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.